A prior randomized clinical trial19 found that LMWH combined with insulin achieved target plasma triglyceride levels (<500 mg/dL [to convert to millimoles per liter, multiply by 0.0113]) in approximately 48 hours in patients with HTG-AP, with reduced respiratory failure incidence compared with hemofiltration and without a serious rebound phenomenon and severe adverse effects. Here, INS is linked to alkaline phosphatase measurement.